tert-Butyl N-[(2S,3S)-2-(hydroxymethyl)tetrahydrofuran-3-yl]carbamate, 98%, 500mg

7-(Benzyloxy)-4-(2-fluoro-4-nitrophenoxy)-6-methoxyquinoline, 98%, 1g

2-Fluoro-3-iodo-4-methoxybenzaldehyde, 98%, 5g

4'-(Heptyloxy)-[1,1'-biphenyl]-4-carbonitrile, 95.0%, 10g

METHYL 2-[(PROPAN-2-YL)AMINO]ACETATE, 95%, 500mg

Nonaethylene Glycol Monododecyl Ether [for Biochemical Research]5g

tert-Butyl 7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate, 95.0%, 1g

ethyl 1-(6-Chloropyridin-2-yl)cyclohexane-1-carboxylate, 98%, 100mg

Needles Point type 3 for GASTIGHT® syringes series 1700, Gesch. for, <= 100 μl, 6 pieces

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid, 95.0%, 1g

6-(TERT-BUTOXYCARBONYL)-2-OXA-6-AZASPIRO[3.4]OCTANE-8-CARBOXYLIC ACID, 95.0%, 250mg

3,3-BIS(BROMOMETHYL)-3,4-DIHYDRO-2H-THIENO[3,4-B][1,4]DIOXEPINE, 95%, 5g

(3-((4-(tert-Butoxycarbonyl)piperazin-1-yl)methyl)phenyl)boronic acid, 98%, 250mg